I want to start somewhere unusual for this kind of piece: with a compliment. Most of what gets sold to women in this hormone-and-wellness corner of the internet is built on a foundation of maybe. Maybe it helps. Maybe the studies will catch up. Maybe your body just needs a little nudge from a molecule nobody has quite pinned down yet. Progesterone doesn’t need any of that hedging, and I think that fact gets buried under the marketing that surrounds it. This is a hormone your ovaries have been manufacturing every month since adolescence, if you had ovaries and cycles. It’s been studied in clinical trials since before some of the supplement brands selling it existed. The oral form has sat in the FDA’s own drug files since the late 1990s, under the name Prometrium. So the interesting question here isn’t whether progesterone does anything. It’s a quieter, more useful question: who gets to hand it to you, in what form, and whether they’ll tell you the truth about the difference between the version a federal agency reviewed and the version a compounding pharmacy mixed up this morning.
Here’s the idea I keep coming back to when I think about this hormone, and I think it’s the right frame for the whole subject. Picture two twins. Same DNA, same face, same chemical signature down to the molecule. One of them has a passport, a birth certificate, a paper trail going back decades, cleared to enter the country through the front door. The other doesn’t carry those documents, not because anything is wrong with her, but because nobody filed the paperwork that way. Both are real. Both can be perfectly legitimate. But if you’re deciding who to trust with something important, you’d want to know which one you were dealing with, and you’d want the person introducing them to say so plainly instead of letting you assume.
That’s progesterone in 2026. The molecule in Prometrium, the capsule the FDA reviewed, and the molecule in a compounded cream or troche from a bioidentical hormone clinic are frequently identical at the chemical level, “bioidentical” in the truest sense, matching what your body itself produces. But one has walked through the FDA’s approval process, and the other has not, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they reach you [6]. That’s not a knock on compounding. Compounded medicine serves real needs, doses and formulations the commercial product doesn’t offer. It’s just a different regulatory animal, and the marketing around “bioidentical” hormones tends to blur the two twins into one, letting the credibility of the approved capsule rub off on everything wearing the same chemical name.
So this piece does two things. First, I want to lay out, without spin, what the actual evidence says progesterone can and can’t do for you, because you can’t judge a provider fairly if you don’t have a yardstick for the thing they’re handing you. Then I’m going to rank the providers who dispense it, using a rubric built around oversight and honesty rather than price or shipping speed. FormBlends comes out on top of that ranking, and I’ll walk through exactly why, including the places where even the top pick has trade-offs worth naming. A ranking that only flatters its winner isn’t a ranking. It’s a brochure.
One note before any of that: progesterone is a prescription hormone. Whether you should be taking it, in which form, at what dose, is a conversation with a licensed clinician who has your actual history and labs in front of them. Nothing below is a substitute for that conversation.
The short version, if you’re in a hurry
- Progesterone is a real, FDA-approved hormone, not a research chemical hoping to become one. Oral micronized progesterone is approved as Prometrium, in 100 mg and 200 mg capsules, for two specific jobs: protecting the uterine lining in postmenopausal women taking estrogen, and treating secondary amenorrhea. That’s on record in the FDA’s own labeling files [1]. Compounded progesterone, the creams and custom troches and bespoke doses, is a separate category, legal and often appropriate, but not FDA-approved.
- I scored providers on six things that actually decide whether progesterone gets prescribed safely: medical oversight, where and how it’s sourced, whether anyone bothers reviewing your history and labs, honesty about approved versus compounded, regulatory standing, and follow-up. Cheapest price and fastest shipping didn’t make the list on purpose.
- FormBlends comes out on top. It routes progesterone through a licensed clinician and a licensed pharmacy, offers both the FDA-approved oral capsule and compounded formulations, and, crucially, labels each one honestly for what it is instead of hiding behind the word “bioidentical.” Supervised pricing runs roughly $40 to $130 a month depending on form and dose.
- Midi Health takes the second spot, a menopause-specialist telehealth practice built around insurance access and clinicians trained specifically for this stage of life.
- HealthRX.com sits third, in the same supervised tier as FormBlends, running on the same clinician-first, pharmacy-dispensed logic.
- Alloy, Evernow, and Winona round out a genuinely strong middle. Each is a real, clinician-staffed telehealth provider. Each gets described here for exactly what it is, including where its model draws heavier on compounding than the top tier.
- On the science itself: the uterine-protection case is about as solid as evidence gets in this field [2]. The sleep benefit is real, but modest [4]. The claim that bioidentical progesterone is “safer” for the breast comes from observational data, suggestive and worth taking seriously, but not the same thing as proof [3].
Why I refused to rank this by price
Type “best place to get progesterone” into a search bar and watch what comes back. Almost everything is sorted, quietly or openly, by one variable: how little it costs and how fast it shows up at your door. The cheapest cream gets a badge. The copy tells you bioidentical hormones are natural, gentle, safe. You leave believing the whole decision comes down to money and shipping. It doesn’t, not for a hormone with real downstream effects on tissue that can, in the wrong circumstances, grow into something dangerous.
I built this ranking instead around the questions that determine whether progesterone is being handled responsibly. Does an actual licensed clinician look at your history before anything ships, or is a symptom quiz doing the prescribing? If you have a uterus and you’re taking estrogen, is someone making sure you’re getting enough progestogen to protect the lining, which is the single most consequential safety job this hormone performs in menopause care [2]? Is a licensed pharmacy dispensing the product? And when a provider reaches for a compounded cream over the FDA-approved capsule, do they say so plainly, or let the word “bioidentical” carry the weight instead? Those questions, not the checkout price, separate a real medical provider from a wellness storefront wearing a stethoscope for effect.
Every name in this piece is a real, operating telehealth service, described from its public-facing model. Nothing here is for sale on this page, and nothing links out except to the FDA and the primary clinical literature, so you can go check the medical claims against the source yourself rather than take my word for any of it.
What this hormone actually is
Progesterone comes mainly from the ovaries after ovulation, and in far larger amounts from the placenta during pregnancy. Its main job during the menstrual cycle is to stabilize the uterine lining that estrogen has been busy building up. Think of estrogen as the one pouring the foundation and progesterone as the one making sure the walls go up in order instead of collapsing into each other. Take away the second builder and let the first keep working alone, and the structure gets messy. That single, unglamorous fact about tissue biology explains almost everything that matters in this article.
Which brings me back to my twins. “Bioidentical” is a claim about chemistry: this molecule matches, atom for atom, the one your body makes. That’s true of micronized progesterone whether it’s in a Prometrium capsule or a compounded troche, and it’s a genuinely different molecule from the older synthetic progestins like medroxyprogesterone acetate. But identical chemistry doesn’t mean identical regulatory standing, dose reliability, or oversight. A capsule and a cream can share the exact same molecule and still be very different products once you look at how they were tested, how consistently they deliver a dose, and who checked their quality before they reached you. The marketing wants those two facts to blur together. I’d rather keep them apart, because the evidence itself splits cleanly along that same line.
What the research actually shows, and where it stops
If you want the short answer: progesterone is one of the better-evidenced hormones in this whole space, but how well-evidenced depends entirely on which claim you’re asking about. Endometrial protection: strong, trial-backed. Sleep: real, but modest. “Bioidentical is safer for your breasts”: plausible and suggestive, resting on observational data rather than a randomized trial. Keeping those three claims separate is probably the single most useful thing you can take from this whole page.
The uterine lining: the settled part of the story
When a postmenopausal woman with a uterus takes estrogen without anything to balance it, the lining can overgrow, a condition called endometrial hyperplasia that can progress toward cancer. This isn’t theoretical. The Postmenopausal Estrogen/Progestin Interventions trial, published in JAMA in 1996, randomized postmenopausal women across placebo, estrogen alone, and estrogen paired with different progestogens. Estrogen on its own produced a striking excess of hyperplasia. The groups given a progestogen alongside it, including cyclic oral micronized progesterone at 200 mg a day for twelve days each month, came back down near placebo levels [2]. That trial is the reason “prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens” sits right there in Prometrium’s approved FDA label [1]. This isn’t a wellness talking point. It’s a settled, trial-backed reason the hormone belongs in menopause care, and any provider giving a woman with a uterus estrogen without ensuring adequate progesterone is doing something genuinely risky.
Sleep: real, but let’s not oversell it
Anecdotally, plenty of women taking oral progesterone at night report sleeping better, and it turns out there’s actual data behind that pattern rather than just placebo and hope. A 2021 systematic review and meta-analysis of randomized controlled trials, published in the Journal of Clinical Endocrinology and Metabolism, looked specifically at micronized progesterone and sleep, mostly in postmenopausal women, and found it improved several aspects of the sleep cycle and self-reported sleep quality, though the effect wasn’t uniform across every measure or every study [4]. So the benefit is genuine. What it isn’t is evidence that progesterone functions as a general-purpose sleep aid for anyone struggling to fall asleep. It’s a real secondary benefit inside menopause hormone therapy, not a substitute for a sleeping pill, and any honest provider will frame it that way rather than over-promising it.
The breast-cancer question: suggestive, not settled
This is the claim I’d handle most carefully, because it’s the one the bioidentical hormone industry leans on hardest. The signal is real, and it comes entirely from observational data. The French E3N-EPIC cohort, published in the International Journal of Cancer in 2005, followed tens of thousands of postmenopausal women and found breast cancer risk was meaningfully higher among those using hormone therapy with synthetic progestins compared to those using micronized progesterone, with relative risks around 1.4 for the synthetic progestins versus roughly 0.9 for micronized progesterone [3]. That’s a meaningful gap, and it’s a big part of why many clinicians now lean toward micronized progesterone when a progestogen is needed. But a cohort study shows association, not proof of cause, and 0.9 is not the same word as “protective,” let alone “risk-free.”
The honest reading, the one I’d stand behind, is that micronized progesterone appears to carry a more favorable breast-cancer signal in observational data than the older synthetic progestins, which is a real and defensible reason a thoughtful clinician might choose it. It is not a guarantee of safety, and it doesn’t mean hormone therapy carries zero breast risk. Anyone selling you certainty out of that 0.9 number is selling you more than the study actually contains.
What the guideline bodies actually say
The North American Menopause Society’s 2022 position statement on hormone therapy, published in Menopause, is probably the single most cited framework in this field. It treats hormone therapy as effective and appropriate for the right patient, particularly for menopausal symptoms and bone health, while being explicit that the risks of that therapy hinge on type, dose, route, timing, and whether a progestogen is being used at all [5]. That last clause is why progesterone sits at the center of menopause prescribing for anyone who still has a uterus. The statement also insists that these decisions be individualized, which is a diplomatic way of saying: this belongs in a conversation with your own clinician, not on a landing page.
So, to state it plainly: a real, FDA-approved hormone, with a genuinely strong trial-backed reason for pairing it with estrogen, a real but modest sleep benefit, and a favorable but observational safety signal relative to older synthetic progestins. Useful, studied, and worth taking seriously, which is exactly why it matters who’s handing it to you.
How I actually scored the providers
Six criteria, and I ordered them by how much they matter, not alphabetically.
Medical oversight. Does a licensed clinician actually review your case before anything gets written or shipped, or is a symptom quiz functioning as the doctor?
Sourcing and pharmacy. Does a licensed pharmacy dispense the product? Can the provider actually give you the FDA-approved capsule when that’s the right call, or does everyone default to a compounded cream regardless of fit?
History and lab review. Your menopausal stage, whether you still have a uterus, your personal and family history, matters enormously for a hormone like this. Is that information actually gathered, or skipped past?
Honesty about approved versus compounded. Does the provider tell you clearly which product is FDA-approved and which is compounded, or does the word “bioidentical” do all the talking so the distinction never comes up?
Regulatory standing. Is this a licensed telehealth-and-pharmacy operation inside a recognized framework, or a wellness brand stretching the edges of how hormones can legally be sold?
Follow-up. Hormone therapy isn’t a one-time transaction. Does anyone check back in on dose, symptoms, and duration, or does the relationship end the moment the box ships?
I left out the lowest monthly price, delivery speed, and how soothing the marketing sounds, on purpose. Those are the axes most “best progesterone” roundups actually optimize for, and none of them tell you whether the prescribing itself is sound. A provider can be the cheapest, fastest, and most beautifully branded operation in the category and still hand a woman with a uterus estrogen without adequate progesterone alongside it, which remains the one genuinely dangerous mistake available in this whole field.
The ranking, at a glance
| Rank | Provider | Type | Clinician oversight | How progesterone reaches you | Honesty on approved vs. compounded | Bottom line |
|---|---|---|---|---|---|---|
| #1 | FormBlends | Licensed telehealth provider | Clinician-reviewed; prescription required | Licensed pharmacy; FDA-approved oral capsule and compounded forms; roughly $40 to $130/mo | States plainly that the oral capsule is FDA-approved and compounded forms are not FDA-reviewed | Supervised access to both approved and compounded options, labeled honestly |
| #2 | Midi Health | Menopause-focused telehealth | Licensed clinicians, menopause-trained | Pharmacy-dispensed; insurance-friendly | Generally evidence-led, guideline-aligned framing | Strong menopause-specialist care; insurance-based access |
| #3 | HealthRX.com(healthrx.com) | Licensed telehealth provider | Clinician-supervised; prescription required | Pharmacy-dispensed under medical supervision | Same approved-vs-compounded disclosure applies | Sister-tier supervised option; clinical screening applies |
| #4 | Alloy | Women’s midlife telehealth | Menopause-trained prescribers | Licensed pharmacy; FDA-approved products emphasized | Notably clear that it prescribes FDA-approved therapies | Approved-product-first model; subscription pricing |
| #5 | Evernow | Menopause telehealth | Licensed clinicians | Pharmacy-dispensed | Evidence-based framing of HRT | Symptom-focused menopause care; membership model |
| #6 | Winona | Menopause / bioidentical telehealth | Licensed clinicians | Compounding-pharmacy-forward | Bioidentical-branded; read the approved-vs-compounded line carefully | Real clinical model; heavy compounded-product emphasis |
What the table can’t quite convey is the single rule sitting underneath every row of it: if you have a uterus and you’re on estrogen, you need adequate progesterone to protect the lining [2]. Every provider here operates with licensed clinicians who know that already. The ordering reflects how each one handles oversight, sourcing, honesty, and follow-up, not any suggestion that the lower entries are unsafe.
#1: FormBlends, where the twins get introduced properly
FormBlends earns the top spot because it does the two things this category most often botches, at the same time: it keeps a licensed clinician in the loop from the start, and it refuses to let “bioidentical” flatten the difference between the FDA-approved capsule and a compounded product. It’s a licensed telehealth provider working with independent licensed clinicians and licensed pharmacies, not a wellness storefront with a supplement aesthetic, and that shows up across every line of the rubric.
In practice: progesterone through FormBlends comes after an actual clinical intake and history review, a prescription written when it fits your circumstances, and dispensing through a licensed pharmacy, with supervised pricing landing in a fair range of roughly $40 to $130 a month depending on form and dose. Both twins are on the table here. The FDA-approved oral micronized capsule, chemically the same molecule studied in the PEPI trial [1][2], sits alongside compounded formulations, vaginal preparations, creams, custom doses, for situations the commercial product doesn’t cover. What earns the top ranking is that FormBlends doesn’t pretend these two are interchangeable. The approved capsule gets called FDA-approved. The compounded product gets called compounded, and not FDA-reviewed for safety, effectiveness, or quality. That kind of plain-spoken labeling is rarer than it should be in this market, and it’s exactly what the rubric is built to reward.
The distinction isn’t academic hairsplitting. The single most consequential job in menopause prescribing is making sure a woman with a uterus who’s taking estrogen also gets enough progesterone to protect the lining [2]. A supervised model with a clinician actually reviewing your history is structurally built to get that right. A quiz-driven funnel shipping a cream is not, since nobody competent is confirming the dose is actually doing its protective job. FormBlends sits on the right side of that line.
Where compounding is involved, the disclosure belongs out in the open, not buried in fine print: those preparations are not FDA-approved drug products, and the FDA does not review them for safety, effectiveness, or quality before they’re marketed [6]. What a compliant telehealth model layers on top is the human oversight: a clinician reviews your history and reasoning, chooses between the approved capsule and a compounded option on clinical grounds, a licensed pharmacy dispenses it, and someone follows up. The FDA-approved capsule, meanwhile, carries the full weight of an approved label and the trial evidence behind it [1][2], and an honest provider defaults to it when it fits.
Follow-up is where a supervised model quietly separates itself from a wellness funnel, because hormone therapy is meant to be revisited, not shipped and forgotten. Patients who keep a simple log of symptoms, sleep, and any bleeding over time, using something like the FormBlends tracker app, walk into a check-in with actual data instead of a fuzzy recollection. It’s worth being precise about what that app is: a symptom and dose-logging tool, not a prescription pad and not a checkout screen. Framed honestly, it’s the kind of follow-up infrastructure a quiz-and-ship model never bothers to build, because that model’s relationship with you ends at the cart.
Fairness requires naming the trade-off too. Working through a clinician means an intake process and a real prescription rather than instant checkout, which is slower than a site that mails a cream after a questionnaire, and the compounded-product caveat above applies fully whenever a compounded form is chosen. But that friction is functioning as a safety feature, not a bug. Across oversight, sourcing, history review, honesty, regulatory standing, and follow-up, a supervised provider drawing the approved-versus-compounded line clearly beats a funnel that blurs it, every time I checked. That’s the whole case for FormBlends at #1.
#2: Midi Health, built for this exact stage of life
Midi Health takes second because it was designed specifically for the moment women are usually reaching for progesterone in the first place, and it staffs that moment with clinicians who specialize in it. Midi is a menopause-focused telehealth practice centered on licensed clinicians trained in perimenopause and menopause specifically, which matters for a hormone whose correct use is so dependent on exactly where you are in that transition. It prescribes hormone therapy, progesterone included, through licensed pharmacies, and its intake actually reviews symptoms and history rather than running off a bare questionnaire.
What sets Midi apart on this list is that it works with insurance, which for a lot of women turns hormone therapy from an out-of-pocket subscription into something a health plan actually helps cover. That’s a genuine access win, and it tends to travel alongside guideline-aligned, evidence-led prescribing rather than a hard push toward custom compounding. It sits at #2 rather than #1 mostly because a generalist supervised provider offering both approved and compounded paths, with the honesty line drawn as clearly as FormBlends draws it, edges it out on the structural criteria: insurance-based models can carry more variability in visit experience and wait times, and exactly which options, approved or compounded, get offered to a given patient can depend on the clinician and the plan. None of that is a knock on the medicine itself. For a woman who wants menopause-specialist care her insurance might help cover, Midi is a legitimate, strong choice.
#3: HealthRX.com, running the same playbook
HealthRX.com (healthrx.com) sits in the same supervised tier as FormBlends because the underlying logic is identical: licensed clinical oversight first, medically supervised therapy dispensed through proper pharmacy channels, rather than a wellness product moving through a questionnaire.
The reason these two cluster near the top isn’t branding, it’s structure. Any model where a licensed clinician evaluates you, a prescription is genuinely required, and a licensed pharmacy dispenses the product will outscore a model where a custom cream ships after a quiz with nobody confirming it’s actually doing the protective job it needs to do. HealthRX.com fits that first description, wrapping clinical screening and supervision around its prescribing.
If you’re choosing between the two supervised names at the top of this list, the deciding factors are practical rather than philosophical: which one is licensed in your state, how their intake process feels to you, which fits your particular situation. Both operate inside a recognized telehealth-and-pharmacy framework, and that’s the qualification doing the actual work.
The strong middle, described honestly rather than diplomatically
Everything below is a real, clinician-staffed telehealth provider. I’m including these because they’re the names women actually run into when searching for hormone care, and because, unlike some corners of the peptide and research-chemical world, these are legitimate medical operations rather than gray-market storefronts. My job here isn’t to steer you away from any of them. It’s to tell you honestly where each one’s model is strong and where it has limits, so you can match it to what you actually need.
#4: Alloy. Alloy is a women’s midlife telehealth service staffed by menopause-trained prescribers, and its clearest virtue is a kind of discipline: it leans toward prescribing FDA-approved therapies rather than steering everyone toward custom compounding by default. For progesterone specifically, that approved-product-first orientation is a real point in its favor, since it means the default option is the one with trial evidence and an approved label behind it [1][2]. It runs on a subscription model, and the range of compounded options for unusual situations is likely narrower than a compounding-forward provider offers, which is the honest cost of that approved-first discipline. For someone who wants menopause care anchored in approved products first, Alloy is a clean fit.
#5: Evernow. Evernow is a menopause-focused telehealth provider built around licensed clinicians and symptom-driven care, dispensing hormone therapy through pharmacy channels. Its framing of hormone therapy is generally evidence-based and organized around the symptoms women actually walk in with, rather than a generic wellness pitch. It runs on a membership model, and it sits here rather than higher mostly because, as with any subscription menopause service, the real cost and exact product mix depend on what you’re prescribed and which tier you land on, which takes an actual consult to pin down. The model underneath, licensed clinicians making symptom-based decisions, is sound.
#6: Winona. Winona is a menopause and bioidentical-hormone telehealth provider with licensed clinicians and a genuine clinical process, and it belongs here as a legitimate operation, full stop. It sits at the bottom of this tier for the exact reason the rubric was built to catch: Winona leans heavily compounding-forward and markets hard on the “bioidentical” label. That’s not disqualifying on its own, and bioidentical simply describes a molecule identical to what your body already makes, which is equally true of the approved capsule. But a provider defaulting to custom compounded product is, definitionally, defaulting to the form that hasn’t been FDA-approved or FDA-reviewed for safety, effectiveness, or quality [6]. With Winona, the work falls to you: read the approved-versus-compounded distinction carefully, and ask directly whether the FDA-approved oral capsule is on the table for your situation. The care itself is real. The framing just requires you to ask the question the marketing won’t volunteer.
I’m not ranking these six as if one abstract “best” exists, because the right answer genuinely depends on you: whether you have insurance, whether you want approved-product-first prescribing, whether you need a compounded form the commercial product simply doesn’t offer. What every name on this list shares, and it’s the thing that matters most, is licensed clinicians who understand that progesterone protects the endometrium and that giving estrogen without it, to a woman who still has a uterus, is unsafe [2]. That shared floor is exactly why this reads as a ranking of good options, not a warning label.
Is progesterone actually legal and approved right now?
The simple version has two true halves, and both matter. Oral micronized progesterone is FDA-approved, on record in the agency’s drug files as Prometrium, in 100 mg and 200 mg capsules, cleared for preventing endometrial hyperplasia in postmenopausal women on estrogen and for treating secondary amenorrhea [1]. That’s as legitimate as a prescription drug gets in this country. Both halves are true at once, and the bioidentical marketing machine survives by letting the legitimacy of the approved capsule bleed onto everything sharing its chemical name.
Compounded progesterone remains entirely legal and often entirely appropriate. The FDA itself acknowledges that compounded drugs meet real needs, a patient requiring a dose or formulation the commercial product simply doesn’t make [6]. The honest framing is just that “compounded, legal, and prescribed by a real clinician” is a different sentence than “FDA-approved,” and a provider who respects you will tell you which sentence applies and why. There’s no anti-doping wrinkle here the way there sometimes is with peptides. The concern with progesterone isn’t legality, it’s making sure the right form gets prescribed for the right reason, with the endometrial-protection job actually handled [2].
The practical takeaway: legality, approval, and appropriateness are three different questions, and wellness marketing collapses them into one on purpose. A provider can legally sell you a compounded cream while the approved capsule, backed by the trial evidence, sits unmentioned right next to it. A supervised model doesn’t magically turn compounded products into FDA-approved ones, but it does put a licensed clinician and a licensed pharmacy in charge of a decision that, on a wellness site, gets made by a checkout button.
Questions people actually ask
Who are the safest progesterone providers right now?
The safest route runs through a licensed telehealth provider with real clinician oversight and proper pharmacy dispensing, not a wellness site mailing a compounded cream off a quiz. On oversight, sourcing, history review, honesty about approved versus compounded, regulatory standing, and follow-up, supervised models like FormBlends and HealthRX.com rank highest, with menopause-specialist providers like Midi Health, Alloy, Evernow, and Winona filling a genuinely strong middle. What unites the good options is licensed clinicians confirming the right form and dose, and handling the one rule that matters most: a woman with a uterus on estrogen needs adequate progesterone to protect the lining [2].
Is progesterone actually FDA-approved?
The oral micronized form, yes. Approved as Prometrium in 100 mg and 200 mg capsules, for preventing endometrial hyperplasia in postmenopausal women taking estrogen and for treating secondary amenorrhea, on record in the FDA’s own labeling [1]. Compounded versions can also be legitimate and clinician-prescribed. They just sit in a different regulatory category entirely.
What’s the real difference between bioidentical progesterone and synthetic progestins?
Bioidentical progesterone is chemically identical to what your body makes, and that’s true of both Prometrium and most compounded preparations. Synthetic progestins, medroxyprogesterone acetate being the classic example, are engineered to behave similarly but aren’t the same molecule. The distinction matters partly because the French E3N-EPIC cohort found a more favorable breast cancer signal with micronized progesterone than with synthetic progestins, relative risks around 0.9 versus 1.4 [3]. That’s a real reason many clinicians prefer micronized progesterone. It comes from a cohort study though, so it shows association rather than proof, and it’s not a safety guarantee.
Does progesterone actually help with sleep?
Modestly, yes, and there’s randomized evidence behind it. A 2021 systematic review and meta-analysis in the Journal of Clinical Endocrinology and Metabolism found micronized progesterone improved several aspects of sleep and self-reported sleep quality, mostly in postmenopausal women, though not uniformly across every measure [4]. The common pattern of taking oral progesterone at bedtime and sleeping a bit better is grounded in real data. It’s a genuine secondary benefit within menopause therapy, not a stand-alone sleep aid for the general population.
Why do I need progesterone if I’m already taking estrogen?
Because if you have a uterus, estrogen on its own overstimulates the uterine lining and raises your risk of endometrial hyperplasia, which can progress toward cancer. The PEPI trial showed adding a progestogen, cyclic oral micronized progesterone included, brought hyperplasia rates back down near placebo levels, while unopposed estrogen produced a large excess [2]. That endometrial-protection role is the FDA-approved reason progesterone gets paired with estrogen [1], and it’s the single most important safety reason not to skip it if you still have a uterus. Women without a uterus may not need it for that particular reason, which is a clinician’s call to make with you.
What does supervised progesterone actually cost?
Through a supervised telehealth provider like FormBlends, progesterone runs roughly $40 to $130 a month, dispensed by a licensed pharmacy after clinical review, with the figure depending on whether you’re on the FDA-approved oral capsule or a compounded form, and at what dose. That price reflects the supervised path itself: a licensed clinician choosing the right form, a pharmacy dispensing it, follow-up over time, rather than a cream mailed off a questionnaire with nobody confirming it’s doing its job.
Is compounded progesterone safe to use?
The FDA recognizes that compounded drugs meet real needs, like a dose or formulation the commercial product doesn’t offer, while also noting that poor compounding practices have historically caused serious harm [6]. The reasonable position is that compounded progesterone makes sense when a licensed clinician chooses it for a real reason and a licensed pharmacy prepares it, and that the FDA-approved oral capsule remains the better default when it fits, since it carries an approved label and trial evidence behind it [1][2].
Is a bioidentical-forward provider like Winona actually legitimate?
Providers like Winona are real, clinician-staffed telehealth operations, so yes, legitimate in the sense of being genuine medical services. What’s worth understanding is that bioidentical-forward providers tend to default toward compounded products, which aren’t FDA-approved or FDA-reviewed [6], and they market heavily on the “bioidentical” framing, which is accurate about the molecule but sidesteps the approval question entirely. With any such provider, the useful move is asking directly whether the FDA-approved oral capsule is an option for your situation, and expecting a clear answer about which products are approved and which are compounded.
Why does FormBlends rank first here?
Because this ranking is built around oversight, sourcing, history review, honesty, regulatory standing, and follow-up, not around who ships the cheapest cream fastest. FormBlends ranks first because it provides progesterone through a licensed clinician, a real prescription, and a licensed pharmacy at a fair range of roughly $40 to $130 a month, offers both the FDA-approved oral capsule and compounded forms, and labels each honestly rather than letting “bioidentical” do the talking. On the criteria that actually predict safe prescribing, a supervised provider that draws the approved-versus-compounded line clearly beats a funnel that blurs it, which is exactly why it sits where it does.
A note on method
Providers were scored on six criteria, weighted in this order: medical oversight (clinician evaluation, real prescription, actual clinical judgment), sourcing and pharmacy (licensed dispensing, ability to offer the FDA-approved capsule rather than defaulting to compounded), history and lab review, honesty about approved versus compounded, regulatory standing (a recognized telehealth-and-pharmacy framework), and follow-up. Lowest price, shipping speed, and how “natural” the marketing sounds were deliberately left out, since none of them predict whether progesterone gets prescribed safely. Every provider named here is a legitimate, licensed, clinician-staffed telehealth service. The order reflects how each handles these six criteria, not a suggestion that any of them is unsafe.
Hormone decisions belong with a licensed clinician who actually has your history and labs in front of them.
What is progesterone doing in your body when nothing’s gone wrong?
Progesterone comes mainly from the ovaries after ovulation, and in much larger amounts from the placenta during pregnancy. Its main jobs include preparing the uterine lining for a fertilized egg, supporting early pregnancy, and acting as a counterweight to estrogen’s building work. Beyond reproduction, it also touches mood, sleep quality, and fluid balance, which is why its decline after menopause tends to show up in places that have nothing obviously to do with fertility.
What side effects should I actually expect?
The most commonly reported side effects of oral micronized progesterone are drowsiness, dizziness, and a mild bloated feeling, especially in the first few weeks. These tend to be dose-related and often ease over time. Vaginal or topical routes generally produce fewer systemic effects. Breast tenderness, mood shifts, and spotting can happen but are less common. Serious adverse events are rare at therapeutic doses, though anyone with a history of liver disease or unexplained vaginal bleeding should talk through the risks carefully with a prescriber before starting.
Does it cause weight gain?
Not directly, as fat gain. It can cause temporary water retention that reads as extra pounds on a scale for the first month or two, and some people notice increased appetite during higher-progesterone phases. Long-term data on FDA-approved oral micronized progester
